Cresset Biomolecular Discovery
From Wikipedia, the free encyclopedia
 |
This article relies on references to primary sources. (November 2011) |
| Industry | Drug Discovery, Chemistry Software |
|---|---|
| Founded | 2002 |
| Founder(s) | Dr. Andy Vinter |
| Headquarters | Welwyn Garden City, United Kingdom |
| Key people | Rob Scoffin, CEO, |
| Website | www.cresset-group.com |
Cresset Biomolecular Discovery Ltd is a chemistry software company formed in 2002, specializing in virtual screening technology used in computational chemistry and medicinal chemistry. The company is based in the UK, and sells mainly to pharmaceutical, biotechnology and academic research groups. Cresset software is based upon Field Point Technology,[1] which uses molecular field extrema as a means of finding biologically relevant regions of molecules.
Cresset has partnerships with Pharmaceutical, Contract Research, Software, and Information Organisations including Syrris, Thompson Reuters, Cambridge Soft, and BioFocus DPI.
Contents |
Products [edit]
- FieldStere, a scaffold hopping and bioisostere replacement tool
- FieldScreen, a virtual screening tool
- FieldAlign, a molecular design and SAR interpretaion tool
- FieldTemplater, profiles active compounds
- Field View, a molecular viewer and editor
- Xed Tools, molecular mechanics force fields
